Cerebellar ataxia, neuropathy and vestibular areflexia syndrome (CANVAS): diagnostic contribution of vestibular function tests
- 1 Otorhinolaryngology, Centro Hospitalar Universitário de Lisboa Central, Lisboa, Portugal
- 2 Neurology, Centro Hospitalar Universitário de Lisboa Central, Lisboa, Portugal
- 3 Neuroradiology, Centro Hospitalar Universitário de Lisboa Central, Lisboa, Portugal
- Correspondence to Dr Patrícia Melo Sousa, Otorhinolaryngology, Centro Hospitalar Universitário de Lisboa Central, Lisboa, Portugal; patriciamelosousa@hotmail.com
Abstract
Cerebellar ataxia, neuropathy and vestibular areflexia syndrome (CANVAS) is a recently recognised but underdiagnosed cause of late-onset hereditary ataxia. Symptoms may vary, and differential diagnoses can span several specialties. We report the case of a man in his 60 s who presented with a 10 year history of imbalance and progressive gait disturbance associated with a chronic spasmodic cough that preceded these symptoms by almost 30 years. He had previously undergone extensive testing for acquired and genetic causes of ataxia without a conclusive diagnosis. Brain MRI revealed cerebellar atrophy, and nerve conduction tests suggested a sensory ganglionopathy. Vestibular function testing was crucial for diagnosis, identifying a severe bilateral vestibulopathy. This led to the consideration of CANVAS, which was finally confirmed by genetic testing. This case raises awareness of this novel genetic disease, highlighting the importance of objective vestibular function tests in establishing an early diagnosis.
Background
Cerebellar ataxia, neuropathy and vestibular areflexia syndrome (CANVAS) is a type of autosomal recessive ataxia with a late onset (fifth to seventh decade of life).1 This syndrome was first described by Szmulewicz et al in 2011,2 and clinical diagnostic criteria were established in 2016.3 The genetic background of CANVAS was recently characterised in 2019 by the identification of a biallelic intronic pentanucleotide (AAGGG) repeat expansion in replication factor complex subunit 1 (RFC1).1 4 Sporadic and familial cases have been reported5 and although its exact prevalence remains unknown, CANVAS is very likely underdiagnosed.1 5 A recent European multicentric study reported the results of a large natural history study in RFC1 disease and demonstrated that it is frequent and occurs across continents.6
The RFC1 gene encodes the large subunit of replication factor C, a 5-subunit DNA polymerase accessory protein required for the coordinated synthesis of both DNA strands during replication or after DNA damage.1 Mutations in DNA repair genes have been associated with some degenerative neurological disorders7 that typically present as ataxia and neuropathy, suggesting a particular susceptibility of the cerebellum and peripheral nerves to DNA damage.1
The disease is slowly progressive, with typical symptoms including gait imbalance (worsened in darkness), limb dysesthesia and oscillopsia with frequent falls.8 Chronic cough has been recognised as a prodromal symptom of CANVAS and can precede gait ataxia by several decades.5 8 9 In addition, dysarthria, dysphagia, dysautonomic signs and neuropathic pain are frequently observed.10–12
CANVAS affects multiple neurological systems, compromising three of the four pillars of balance: cerebellar, proprioceptive and vestibular functions (only vision remains intact). Patients with CANVAS have impaired, slow stabilising eye movements (vestibulo-ocular reflex (VOR), smooth pursuit and optokinetic reflex) responsible for gaze stabilisation during head motion, causing a deficient visually enhanced vestibulo-ocular reflex (VVOR) with clinically detectable catch-up saccades, a characteristic clinical sign.13 14
CANVAS is likely to be underdiagnosed due to its variability of symptoms (type and onset) and the potential need for multiple specialties for a definite diagnosis. Furthermore, particular expertise is required in interpreting diagnostic tests, which may not be available in every setting. In particular, vestibular deficits may go unrecognised if vestibular function tests are not performed.12
We present a case of CANVAS and highlight the importance of comprehensive clinical and diagnostic investigations with a special emphasis on vestibular function tests to confirm bilateral vestibulopathy. This condition has rarely been reported in Portugal, and to the best of our knowledge, this is the only case reported after Malaquias et al described the first four cases of Portuguese familial CANVAS with pathogenic RFC1 expansion and autosomal recessive inheritance.15
Case presentation
A man in his 60s presented to the otolaryngology department on referral by his neurologist for imbalance, gait disturbance and falls over the last 10 years. His symptoms were slowly progressive, initially with walking difficulty and unsteady gait that gradually worsened, mostly in the dark and on uneven ground, with increasing occasional falls. He also presented with a long-standing chronic cough since the age of 30 years that usually came in bursts without apparent triggering factors. He had no dysphagia, dysarthria or symptoms of autonomic dysfunction. His personal medical history included depression, for which he was taking 150 mg of venlafaxine daily. He was unaware of other relatives with similar symptoms.
Neurological examination showed wide-based truncal ataxia, impossible tandem gait and instability in the Romberg test. Downbeat nystagmus was present, the clinical head-impulse test was pathological bilaterally, and saccadic eye movements were observed while examining for VVOR. Upper-limb and lower-limb tendon jerks were preserved, and the flexor plantar reflex was present. Vibration sensation was impaired distally (upper and lower extremities), but pinprick and joint position sensations were intact. Muscle strength was normal. He had slight bilateral heel-knee and finger-to-nose dysmetria.
The patient had been previously investigated as a neurology outpatient with nerve conduction studies that revealed the absence of sensory nerve action potentials in all limbs and normal motor nerve conduction studies, suggesting a sensory neuronopathy. Brain MRI revealed atrophy of the anterior and dorsal vermis (predominantly in lobules V, VI, VIIA and VIIB) and widening of the superior posterior and horizontal fissures of the cerebellar hemispheres (mild atrophy of Crus I), without signal changes; the cerebrum and brainstem parenchyma were unremarkable (figure 1). Given these findings, causes of acquired cerebellar degeneration were investigated with extensive laboratory testing, including protein electrophoresis; vitamins B1, B6, B12 and E; thyroid hormones; an immunology panel containing antineuronal antibodies (Hu, Yo, Ri, CV2, PNMA2, amphiphysin), antigliadin, and anti-t-transglutaminase; and infectious serologies, which were unremarkable. He was genetically tested for Friedreich’s ataxia and the most common spinocerebellar ataxias (SCAs) by a genetic panel (144 genes) that included ATXN1 (SCA1), ATXN2 (SCA2), ATXN3/DMJ (SCA3), CACNA1A (SCA6), ATXN7 (SCA7), TBP (SCA17) and ATN1 (DRPLA), which were all negative. His chronic cough had also been previously investigated by the pneumology department, but no organic cause was found.
Brain MRI. (A) Sagittal T1-weighted image shows anterior and dorsal vermis atrophy, predominantly in lobules V, VI, VIIA and VIIB. (B) Parasagittal T1-weighted image at cerebellar hemisphere with widening of superior posterior and horizontal fissures (mild atrophy of Crus I).
Investigations
In order to establish a diagnosis, a comprehensive audiovestibular assessment, including pure-tone audiometry, videonystagmography with bithermal caloric test, video head impulse test (vHIT) and ocular and cervical vestibular evoked myogenic potentials (oVEMP and cVEMP), was conducted at the otolaryngology department. Audiometry demonstrated normal hearing for age. Videonystagmography showed downbeat nystagmus, saccadic horizontal and vertical pursuit, hypermetric saccades and impaired VVOR (figure 2). He had caloric areflexia, and vHIT showed decreased VOR gains for all semicircular canals with compensatory saccades (figure 3). cVEMP revealed absent responses on the left side and low amplitude responses with a high threshold on the right (figure 4A). oVEMP responses were absent on the left side and normal on the right (figure 4B).
Videonystagmography showing eye movement abnormalities. (A) Vertical downbeat nystagmus. (B) Saccadic horizontal smooth pursuit. (C) Horizontal saccadic dysmetria (target overshoot—arrowheads). (D) Slow sinusoidal head rotation displaying impaired visually enhanced vestibulo-ocular reflex (VVOR) with refixation saccades (arrowheads).
Video head impulse test showing bilateral vestibulopathy with reduced vestibulo-ocular reflex gains and compensatory (catch-up) saccades for all semicircular canals (arrows). LH, left horizontal; LA, left anterior; LP, left posterior; RH, right horizontal; RP, right posterior; RA, right anterior.
(A) Cervical vestibular evoked myogenic potential (cVEMP) responses present on the right side (with low amplitude and high threshold at 105 dBnHL) and absent on the left. (B) Ocular vestibular evoked myogenic potential (oVEMP) responses normal on the right side and absent on the left (vestibular evoked myogenic potential (VEMP) stimulus—500 Hz air conducted tone bursts). L, left side; R, right side.
These findings of bilateral vestibulopathy associated with cerebellar ataxia and sensory neuronopathy suggested CANVAS, which was confirmed by the biallelic repeat expansion in the RFC1 gene on genetic testing.
Differential diagnosis
The association of cerebellar ataxia, vestibular deficit and sensory neuropathy may be observed in hereditary ataxias, such as Friedreich’s ataxia and SCAs (particularly SCA1 and SCA3), as well as in mitochondrial diseases,12 16 and affected patients may have clinical features similar to CANVAS. In addition, since autonomic dysfunction can be a feature of CANVAS,11 multiple system atrophy with predominant cerebellar ataxia (MSA-C) should also be considered as a differential diagnosis, especially in patients who present with ataxia and autonomic failure (which was not the case in this patient). The absence of a vestibular deficit, more rapid disease progression and brainstem atrophy may help differentiate MSA-C from CANVAS.11
Infectious, metabolic, paraneoplastic and immune-mediated peripheral neuropathies should also be considered and laboratory investigations must be carried out accordingly,17 as was done in this patient’s case.
In addition, peripheral neuropathy and cerebellar ataxia can be associated with chronic alcoholic intoxication, and vestibular deficits have been observed in Wernicke’s encephalopathy due to thiamine deficiency.18 This should be explored in the patient’s history and with laboratory testing, which excluded this diagnosis in our case.
Treatment
The patient was referred to physiotherapy and started a personalised rehabilitation programme (two times per week over 8 weeks), which focused on balance and gait training and consisted of static and dynamic balance exercises (eg, standing on one leg, standing heel to toe, sidesteps, climbing stairs, sitting on a Swiss ball), and whole-body movements to train trunk-limb coordination. Strength and flexibility training were also performed to improve muscle strength and range of motion. The patient was encouraged to continue exercises at home according to an individual written training schedule of safe tasks. Fall prevention strategies were also implemented by identifying and avoiding potential environmental and home fall hazards, improving lighting conditions and wearing appropriate footwear.
Outcome and follow-up
After 1 year of follow-up and customised physical rehabilitation, the patient maintains gait instability but is able to walk without assistance. Physiotherapy has not improved gait disturbance but has helped with physical conditioning and muscle strengthening. The patient’s disability level has not worsened, allowing him to continue his work activities.
Discussion
CANVAS may be a frequent but underdiagnosed genetic cause of late-onset progressive ataxia.1 6 19 However, in contrast to the present patient, the full clinical picture is not always present, which can delay diagnosis. When the symptomatic triad is complete, the sensitivity of genetic testing is very high, even in sporadic cases, and testing for RFC1 gene mutations should be performed, especially when an acquired cause of ataxia is excluded.
We reported a case of CANVAS with symptoms lasting for 10 years with no diagnosis. After a thorough multidisciplinary investigation, the patient finally met the clinical diagnostic criteria for a definitive diagnosis of CANVAS.3 Objective vestibular function testing was crucial, allowing confirmation of bilateral vestibulopathy affecting all vestibular end organs (semicircular canals, saccule and utricle).
Recent technological advances have made it possible to completely study the vestibular end organs in the inner ear. Videonystagmography allows for the identification of oculomotor signs of cerebellar impairment and often shows dysmetric saccades, saccadic smooth pursuit and altered optokinetic nystagmus.13 20 In most patients with CANVAS, response to caloric testing is absent or severely reduced bilaterally, and vHIT demonstrates low VOR gain and compensatory saccades.8 12 Otolith organ function has not been widely studied in CANVAS, and to the best of our knowledge, this is one of the few reports in the literature describing the use of VEMP to evaluate vestibular function in CANVAS.21–23 The few available studies (mostly case series or case reports) show great variability in otolithic function, ranging from normal to absent responses.21–23
In this patient, vestibular function testing showed severe bilateral impairment of the VOR of the semicircular canals (both on caloric tests and vHIT testing) and partial dysfunction of the otolith organs (saccule and utricle) on VEMP testing, with absent cVEMP and oVEMP ipsilaterally and otolithic function preserved contralaterally. Although diagnostic criteria for bilateral vestibulopathy do not consider otolith function,24 we consider VEMP testing important because it allows for assessment of the range of vestibular impairment. We speculate that this may be of prognostic interest by indicating disease progression and severity. However, more investigations are needed to assess the effects of otolith dysfunction on the prognosis of the disease and to determine the utility of VEMP testing in CANVAS.
These results should also be discussed in the context of current knowledge regarding the histopathology of CANVAS. To date, there has only been one postmortem study in a patient with CANVAS demonstrating bilateral neuropathy of the vestibular (Scarpa’s) ganglion and nerve, with a severe decrease in Scarpa’s ganglion cells, atrophy of peripheral and central axons, and intact vestibular sense organs (cristae and maculae), cochlear nerve and its spiral ganglion.2 These findings suggest that the vestibular areflexia of CANVAS is due to neuronopathy (vestibular ganglionopathy).10 As a result, we anticipate that degeneration of the vestibular ganglion may cause a global loss of function of the semicircular canals as well as otolith organs. However, some studies have demonstrated that severely impaired canal function can coexist with partial sparing of otolithic function, as reflected by VEMP responses,21 22 as was the case in our patient. Yacovino et al 22 hypothesised that if the vestibular areflexia in CANVAS was due to ganglionopathy, there should be an overall decline in all vestibular responses. However, the preservation of VEMP responses rejects this hypothesis, as these should also be affected. To explain the preservation of the VEMP in their case, Rust et al 21 suggested that the degenerative process may be on the vestibular nuclei or tracts connecting cerebellar structures with the brainstem, this being the cause for the selective loss of bilateral semicircular function but preserved otolith responses. Current knowledge is insufficient, and further VEMP studies are needed to elucidate the pathophysiology of these findings in CANVAS.
Current disease management is limited to supportive care, as there is no cure or effective medical treatment. Physiotherapy is only mildly effective but may help with physical conditioning. Patients should be counselled about fall prevention and referred for personalised rehabilitation.
In conclusion, this report highlights the importance of investigating and recognising the key clinical features of CANVAS, particularly bilateral vestibulopathy, which can be demonstrated by objective vestibular tests. Given the diverse clinical presentation and slow disease progression, most patients are seen by different specialties and considered ‘difficult cases’ with no diagnosis. Instead, there must be multidisciplinary collaboration among specialties to facilitate an early diagnosis.
Learning points
-
Cerebellar ataxia, neuropathy and vestibular areflexia syndrome is one of the most common genetic causes of progressive late-onset ataxia and is underdiagnosed due to its myriad symptoms and general unawareness of the condition.
-
Vestibular disorder is one of the main diagnostic pillars, and vestibular function tests allow confirmation of bilateral vestibulopathy.
-
Cough is a frequent prodromal sign and can precede gait ataxia for several decades.
-
Targeted genetic testing (RFC1 gene mutation) should be performed after excluding acquired causes of ataxia.
-
Fostering collaboration among specialties is key to a successful early diagnosis.
Ethics statements
Patient consent for publication
Footnotes
-
Contributors PMS, MF and JJ were responsible for drafting of the text, sourcing and editing clinical images, investigation results, drawing original diagrams and algorithms, critical revision for important intellectual content, and final approval of the manuscript.
-
Funding The authors have not declared a specific grant for this research from any funding agency in the public, commercial or not-for-profit sectors.
-
Case reports provide a valuable learning resource for the scientific community and can indicate areas of interest for future research. They should not be used in isolation to guide treatment choices or public health policy.
-
Competing interests None declared.
-
Provenance and peer review Not commissioned; externally peer reviewed.
- © BMJ Publishing Group Limited 2023. No commercial re-use. See rights and permissions. Published by BMJ.
References
Use of this content is subject to our disclaimer